Intraparenchymal Injection of Bone Marrow Mesenchymal Stem Cells Reduces Kidney Fibrosis after Ischemia-Reperfusion in Cyclosporine-Immunosuppressed Rats

Intraparenchymal Injection of Bone Marrow Mesenchymal Stem Cells Reduces Kidney Fibrosis after Ischemia-Reperfusion in Cyclosporine-Immunosuppressed Rats

Ischemia-reperfusion and immunosuppressive therapy are a major cause of progressive renal failure after kidney transplantation. Recent studies have shown that administration of bone marrow mesenchymal stem cells (MSCs) improves kidney functional recovery in the acute phase of post ischemia-reperfusi...

Full description

Bibliographic Details
Main Authors: C. Alfarano, C. Roubeix, R. Chaaya, C. Ceccaldi, D. Calise, C. Mias, D. Cussac, J. L. Bascands, A. Parini
Format: Article
Language:English
Published: SAGE Publishing 2012-09-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368912X640448

Similar Items

Similar Items